Risk factors in pediatric stem cell transplantation for leukemia
Author:
Publisher
Wiley
Subject
Transplantation,Pediatrics, Perinatology and Child Health
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-3046.2004.00175.x/fullpdf
Reference57 articles.
1. Treatment of acute lymphoblastic leukemia. 30 years’ experience at St. Jude Children's Research Hospital;Rivera;N Engl J Med,1993
2. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients;Reiter;Results and conclusions of the multicenter trial ALL-BFM 86. Blood,1994
3. Intensification of treatment and survival in all children with lymphoblastic leukemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia;Chessells;Lancet,1995
4. Childhood leukemias;Pui;N Engl J Med,1995
5. Intensified treatment of acute childhood lymphoblastic leukemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO);Gustafsson;Acta Paediatr,1998
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Consideration of biological sex in stem cell therapies;Principles of Gender-Specific Medicine;2023
2. The Influence of Human Leukocyte Antigens in Graft Versus Host Disease and Survival After Hematopoiet ic Stem Cell Transplantation in Pediatric Patients with Leukemia;Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy;2021-12-17
3. Recombination frequencies of human leukocyte antigen loci in hematological malignancies among Turkish population;International Journal of Laboratory Hematology;2021-06-07
4. BSHI guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation;International Journal of Immunogenetics;2021-02-10
5. Cytomegalovirus reactivation posthematopoietic stem cell transplantation (HSCT) and type of graft: A step toward rationalizing CMV testing and positively impacting the economics of HSCT in developing countries;Pediatric Blood & Cancer;2017-05-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3